Application | Comment | Organism |
---|---|---|
additional information | conformational changes of the dimer upon covalent binding reproduced by molecular dynamics simulations of the noncovalent complex model, demonstrating that the HCMV protease operates by an induced-fit mechanism. Catalytic activity of the dimer is a result of more favorable interactions between the oxyanion in the covalently bound state and the backbone nitrogen of Arg165 | Human betaherpesvirus 5 |
Crystallization (Comment) | Organism |
---|---|
crystal structure of HCMV protease in complex with the peptidomimetic inhibitor BILC 821 as protease model. Only the dimeric form of the protease is able to reorient the main-chain atoms of Arg165 along the reaction coordinate in order to stabilize more efficiently the oxyanion formed in the reaction pathway | Human betaherpesvirus 5 |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
BILC 821 | - |
Human betaherpesvirus 5 |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Human betaherpesvirus 5 | - |
- |
- |
Subunits | Comment | Organism |
---|---|---|
homodimer | crystallography | Human betaherpesvirus 5 |
Synonyms | Comment | Organism |
---|---|---|
HCMV protease | - |
Human betaherpesvirus 5 |
human cytomegalovirus protease | - |
Human betaherpesvirus 5 |